Cancer
Conditions
Interventions
Control group:Both groups of patients used Bard Medical Technology Co., Ltd. model 7655405 three-way valve PICC catheters, Beijing Gishield Medical Devices Co., Ltd. model 01C-NC100 infusion connector
Intervention group:Patients in both groups used three-way valve PICC catheters (model 7655405, Bard Medical Technology Co., Ltd.), infusion connectors (model 01C-NC100, Beijing Gishield Medical Device
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: (1) Patients with malignant tumors admitted to the research hospital of this project must have a three-way valve PICC initially inserted for chemotherapy, and during the 3-week treatment interval after discharge with the catheter, they must consistently attend the intravenous catheter care clinic of the trial group for catheter maintenance. (2) During the first maintenance visit to the IV therapy clinic of this center after discharge, the catheter function is assessed to be fully patent, with no complications such as infection or symptomatic thrombosis. (3) Patients assessed using the Venous Thromboembolism (VTE) Risk Assessment Scale and the Catheter Thrombosis Risk Assessment Scale are not classified as high-risk. (4) Normal coagulation function, no history of vascular disease, and no contraindications to medication use. (5) Aged 18–69 years, regardless of gender. (6) Patients have unrestricted mobility. (7) Expected survival time >1 month. (8) Patients are willing to participate, cooperate in completing this clinical study, and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) The PICC catheter tip is not located in the middle to lower third of the superior vena cava. (2) Presence of bleeding or coagulation abnormalities, or recent receipt of other anticoagulation therapy. (3) The current treatment interval after the first assessment is less than 3 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of catheter occlusion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of catheter-associated infection;Catheter-related symptomatic thrombosis rate;Patient direct costs associated with catheter care/maintenance;Time cost of infusion therapy clinic specialist nurses; | — |
Countries
China
Contacts
Public ContactJiasi Zhang
The First Affiliated Hospital of Army Medical University
Outcome results
None listed